Detalhe da pesquisa
1.
A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness.
Antimicrob Agents Chemother
; 68(4): e0127323, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376227
2.
Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection.
Drugs R D
; 21(4): 455-465, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741731